切换至 "中华医学电子期刊资源库"
高级检索
中华实验和临床感染病杂志(电子版)

中华实验和临床感染病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (04) : 257 -262. doi: 10.3877/cma.j.issn.1674-1358.2021.04.007

论著

血清肝素结合蛋白、C-反应蛋白和降钙素原对肺癌电视胸腔镜术后肺部细菌感染的预测价值
王伟1,†(), 王坤1, 孙涛1, 茹玉航1, 刘晓1   
  1. 1. 236800　亳州市，亳州市人民医院胸外科
  • 收稿日期:2020-08-31 出版日期:2021-08-15
  • 通信作者: 王伟
  • 基金资助:
    安徽省高等学校省级质量工程教学项目(No. 2018jyxm04)

Predictive value of serum heparin binding protein, C-reactive protein and procalcitonin for pulmonary bacterial infection after video-assisted thoracoscopic surgery for lung cancer

Wei Wang1,†(), Kun Wang1, Tao Sun1, Yuhang Ru1, Xiao Liu1   

  1. 1. Department of Chest Surgery, Bozhou People’s Hospital, Bozhou 236800, China
  • Received:2020-08-31 Published:2021-08-15
  • Corresponding author: Wei Wang
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

王伟, 王坤, 孙涛, 茹玉航, 刘晓. 血清肝素结合蛋白、C-反应蛋白和降钙素原对肺癌电视胸腔镜术后肺部细菌感染的预测价值[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(04): 257-262.

Wei Wang, Kun Wang, Tao Sun, Yuhang Ru, Xiao Liu. Predictive value of serum heparin binding protein, C-reactive protein and procalcitonin for pulmonary bacterial infection after video-assisted thoracoscopic surgery for lung cancer[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2021, 15(04): 257-262.

目的

探讨血清肝素结合蛋白（HBP）、C-反应蛋白（CRP）和降钙素原（PCT）对肺癌患者电视胸腔镜手术（VATS）术后肺部细菌感染的预测价值。

方法

回顾性分析2017年3月至2020年7月亳州市人民医院收治的105例肺癌患者的临床资料。统计肺癌患者VATS术后肺部细菌感染发生率；根据术后是否发生肺部细菌感染将患者分为感染组（18例）与对照组（87例），比较两组患者术后即刻、术后24 h血清HBP、CRP和PCT水平及变化率；绘制受试者工作特征曲（ROC）分析血清HBP、CRP和PCT水平变化率及三者联合预测肺癌患者VATS术后肺部细菌感染的价值。

结果

肺癌患者VATS术后肺部细菌感染的发生率为17.14%（18/105）；与术后即刻相比，术后24 h两组患者血清HBP、CRP和PCT水平均升高[感染组：（12.52 ± 1.53）ng/ml vs.（8.16 ± 1.25）ng/ml，t = 9.363、P < 0.001；（41.83 ± 4.75）mg/ml vs.（21.68 ± 2.18）mg/ml，t = 16.357、P < 0.001；（1.21 ± 0.21）ng/ml vs.（0.32 ± 0.04）ng/ml，t = 17.663、P < 0.001。对照组：（9.94 ± 1.47）ng/ml vs.（7.91 ± 1.17）ng/ml，t = 10.078、P < 0.001；（31.62 ± 3.37）mg/ml vs.（21.27 ± 2.02）mg/ml，t = 24.571、P < 0.001；（0.65 ± 0.07）ng/ml vs.（0.34 ± 0.06）ng/ml，t = 31.363、P < 0.001]；且感染组患者均显著高于对照组（t = 6.732、10.850、20.282，P均< 0.001），差异均有统计学意义。术后即刻至术后24 h感染组患者血清HBP[（53.43 ± 6.82）vs.（25.66 ± 4.51）%]、CRP[（92.94 ± 8.73）% vs.（48.66 ± 6.12）%]和PCT[（278.13 ± 34.75）% vs. （91.18 ± 10.36）%]变化率均高于对照组，差异均有统计学意义（t = 21.596、25.824、42.475，P均< 0.001）。血清HBP、CRP、PCT变化率单独与联合预测肺癌患者VATS术后肺部细菌感染发生的ROC分析显示，血清HBP、CRP、PCT变化率预测肺癌患者VATS术后肺部细菌感染的最佳截断点分别为32.93%、71.65%和128.75%；血清HBP、CRP、PCT三者水平变化率联合预测肺癌患者VATS术后肺部细菌感染的曲线下面积（AUC）为0.848，高于血清HBP（AUC：0.689）、CRP（AUC：0.656）和PCT变化率（AUC：0.612）单独预测的AUC（Z = 2.392、P = 0.017，Z = 2.601、P = 0.009，Z = 2.013、P = 0.048）。

结论

VATS术后即刻至术后24 h，肺癌患者VATS术后发生肺部细菌感染者血清HBP、和CRP和PCT水平升高变化率均高于未发生肺部细菌感染者；血清HBP、CRP和PCT三者水平变化率联合预测肺癌患者VATS术后肺部细菌感染的效能高于各单一指标变化率。

关键词: 肝素结合蛋白, C-反应蛋白, 降钙素原, 肺癌, 肺部细菌感染, 术后并发症, 电视胸腔镜
Objective

To investigate the predictive value of serum heparin-binding protein (HBP), C-response protein (CRP), and procalcitonin (PCT) for pulmonary bacterial infection of patients with lung cancer after video assisted thoracoscopic surgery.

Methods

Clinical data of 105 patients with lung cancer admitted to Bozhou People’s Hospital from March 2017 to July 2020 were analyzed, retrospectively. The incidence rate of pulmonary bacterial infection of patients with lung cancer after VATS was analyzed. The patients were divided into infection group (18 cases) and control group (87 cases) according to whether occurred pulmonary bacterial infection after operation, and the levels of serum HBP, CRP and PCT were compared between the two group immediately and 24 hours after operation. The predictive value of change rates of serum HBP, CRP, PCT levels and the combination of the three indexes on pulmonary bacterial infection for patients with lung cancer after VATS were analyzed by receiver operating characteristic curve (ROC).

Results

The incidence rate of pulmonary infection after VATS was 17.14% (18/105). The levels of serum HBP, CRP and PCT of the two groups increased at 24 hours after operation compared with those immediately after operation, [Infection group: (12.52 ± 1.53) ng/ml vs. (8.16 ± 1.25) ng/ml; t = 9.363, P < 0.001. (41.83 ± 4.75) mg/ml vs. (21.68 ± 2.18) mg/ml; t = 16.357, P < 0.001. (1.21 ± 0.21) ng/ml vs. (0.32 ± 0.04) ng/ml; t = 17.663, P < 0.001. Control group: (9.94 ± 1.47) ng/ml vs. (7.91 ± 1.17) ng/ml; t = 10.078, P < 0.001. (31.62 ± 3.37) mg/ml vs. (21.27 ± 2.02) mg/ml; t = 24.571, P < 0.001. (0.65 ± 0.07) ng/ml vs. (0.34 ± 0.06) ng/ml; t = 31.363, P < 0.001], which were significantly higher of patients in infection group than those of control group (t = 6.732, 10.850, 20.282; all P < 0.001). The change rates of serum HBP, CRP and PCT of infection group were significantly higher than those of control group [(53.43 ± 6.82)% vs. (25.66 ± 4.51)%, (92.94 ± 8.73)% vs. (48.66 ± 6.12)%, (278.13 ± 34.75) % vs. (91.18 ± 10.36)%], with significant differences (t = 21.596, P < 0.001; t = 25.824, P < 0.001; t = 42.475, P < 0.001). ROC analysis on predicting pulmonary bacterial infection after VATS for patients with lung cancer showed that the best cut-off points of change rates of serum HBP, CRP and PCT were 32.93%, 71.65% and 128.75%, respectively. The area under curve (AUC) of the combined three indexes on predicting pulmonary bacterial infection after VATS was 0.848, which was higher than those of serum HBP (0.689), CRP (0.656) and PCT (0.612) (Z = 2.392, P = 0.017; Z = 2.601, P = 0.009; Z = 2.013, P = 0.048).

Conclusions

The increasing change rates of serum HBP, CRP and PCT levels of patients with pulmonary bacterial infection after VATS were higher than those of patients without pulmonary infection immediately and 24 hours after VATS. The combination of change rates of serum HBP, CRP and PCT levels was more suitable for predicting pulmonary bacterial infection of patients with lung cancer after VATS than those of single index.

Key words: Heparin binding protein, C-reactive protein, Procalcitonin, Lung cancer, Pulmonary bacterial infection, Postoperative complications, Video assisted thoracoscopy
表1 入组105例肺癌患者的一般资料
一般资料 数值
性别[例（%）]  
  男 63（60.00）
  女 42（40.00）
平均年龄（± s，岁） 48.65 ± 5.73
肺癌种类（周围型） [例（%）] 105（100.00）
肺癌病理类型[例（%）]  
  腺癌 83（79.05）
  鳞癌 13（12.38）
  腺鳞癌 9（8.57）
肺癌分期[例（%）]  
  Ⅰ期 73（69.52）
  Ⅱ期 32（30.48）
合并基础疾病[例（%）]  
  高血压 27（25.71）
  糖尿病 21（20.00）
  脑血管病 6（5.71）
  其他 4（3.81）
饮酒史[例（%）] 55（52.38）
吸烟史[例（%）] 47（44.76）
表2 感染组和对照组患者术后即刻、术后24 h血清HBP、CRP和PCT水平及变化率（± s）
组别 例数 HBP CRP PCT
术后即刻（ng/ml） 术后24 h （ng/ml） 变化率（%） 术后即刻（mg/ml） 术后24 h （mg/ml） 变化率（%） 术后即刻（ng/ml） 术后24 h （ng/ml） 变化率（%）
感染组 18 8.16 ± 1.25 12.52 ± 1.53 53.43 ± 6.82 21.68 ± 2.18 41.83 ± 4.75 92.94 ± 8.73 0.32 ± 0.04 1.21 ± 0.21 278.13 ± 34.75
对照组 87 7.91 ± 1.17 9.94 ± 1.47 25.66 ± 4.51 21.27 ± 2.02 31.62 ± 3.37 48.66 ± 6.12 0.34 ± 0.06 0.65 ± 0.07 91.18 ± 10.36
t值   0.816 6.732 21.596 0.773 10.850 25.824 1.351 20.282 42.475
P值   0.417 < 0.001 < 0.001 0.441 < 0.001 < 0.001 0.180 < 0.001 < 0.001
图1 血清HBP、CRP、PCT变化率及三者联合预测肺癌患者VATS术后肺部细菌感染的ROC图
表3 血清HBP、CRP、PCT变化率及三者联合对肺癌患者VATS术后肺部细菌感染的预测价值
检测指标 最佳截断点（%） 灵敏度（%） 特异度（%） AUC 95%CI
血清HBP变化率 32.93 88.89（16/18） 59.77（52/87） 0.689 0.591~0.775
CRP变化率 71.65 83.33（15/18） 62.07（54/87） 0.656 0.557~0.746
PCT变化率 128.75 72.22（13/18） 72.41（63/87） 0.612 0.512~0.706
联合 — 72.22（13/18） 98.85（86/87） 0.848 0.765~0.911
[1]
Mun M, Nakao M, Matsuura Y, et al. Video-assisted thoracoscopic surgery lobectomy for non-small cell lung cancer[J]. Gen Thorac Cardiovasc Surg,2018,66(11):626-631.
[2]
李波. 电视胸腔镜手术治疗原发性肺癌的疗效观察[J]. 中华肿瘤防治杂志,2018,25(1):71-72.
[3]
Houston KA, Mitchell KA, King J, et al. Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county[J]. J Thorac Oncol,2018,13(4):497-509.
[4]
唐小娟，侯思远，刘美，等. 肝素结合蛋白在感染性肺炎诊断中的价值分析[J]. 临床检验杂志,2020,38(1):66-69.
[5]
Stjärne Aspelund A, Hammarström H, Inghammar M, et al. Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients[J]. Am J Transplant,2018,18(2):444-452.
[6]
杨思园，顾红岩，崔蓉. 外周血白细胞计数、淋巴细胞百分比和C-反应蛋白与呼吸道病毒检出率的相关性[J/CD]. 中华实验和临床感染病杂志(电子版),2018,12(6):565-569.
[7]
Ericksen RT, Guthrie C, Carroll T. The use of procalcitonin for prediction of pulmonary bacterial coinfection in children with respiratory failure associated with viral bronchiolitis[J]. Clin Pediatr (Phila),2019,58(3):288-294.
[8]
中华医学会，中华医学会肿瘤学分会，中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2018版)[J]. 中华肿瘤杂志,2018,40(12):935-964.
[9]
中华人民共和国卫生部. 医院感染诊断标准(试行)摘登(1)[J]. 新医学,2005,36(8):495-495.
[10]
Matsuoka K, Yamada T, Matsuoka T, et al. Video-assisted thoracoscopic surgery for lung cancer after induction therapy[J]. Asian Cardiovasc Thorac Ann,2018,26(8):608-614.
[11]
刘艳丽. PCT, hs-CRP, WBC及NEUT在肺部感染诊断中的临床价值[J]. 解剖学研究,2017,39(1):58-61.
[12]
Kerget B, Kerget F, Koçak AO, et al. Are serum interleukin 6 and surfactant protein D levels associated with the clinical course of COVID-19[J]. Lung,2020,198(5):777-784.
[13]
赖荣昌，莫松柳，莫凤兴. 参芪扶正注射液辅助治疗肺癌合并阻塞性肺部感染者的疗效及对血清细胞因子的影响[J/CD]. 中华实验和临床感染病杂志(电子版),2020,30(8):124-129.
[14]
张化芝，郭晓烨，李晓双，等. 肺癌术后并发肺部感染的病原学分析及影响因素分析[J]. 中华医院感染学杂志,2018,28(1):77-80.
[15]
Fisher J, Linder A, Bentzer P, et al. Is Heparin-binding protein inhibition a mechanism of albumin’s efficacy in human septic shock[J]. Crit Care Med,2018,46(5):e364-e374.
[16]
Higaki M, Shintani T, Hamada A, et al. Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresses squamous cell carcinoma cell growth by targeting heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1)[J]. In Vitro Cell Dev Biol Anim,2020,56(3):222-233.
[17]
王志尚. C反应蛋白,中性粒细胞-淋巴细胞比率和血清白蛋白为基础的炎症预后指数对非小细胞肺癌预后作用的研究[J]. 临床肺科杂志,2018,23(1):160-164.
[18]
Karasahin O, Tasar PT, Timur O, et al. The value of C-reactive protein in infection diagnosis and prognosis in elderly patients[J]. Aging Clin Exp Res,2018,30(6):555-562.
[19]
段永强，余辉，王钢胜，等. 降钙素原对中晚期肺癌患者化疗期间感染的诊断效率[J/CD]. 中华实验和临床感染病杂志(电子版),2015,9(1):82-85.
[20]
Hovold G, Palmcrantz V, Kahn F, et al. Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis[J]. BMC Pulm Med,2018,18(1):104.
[21]
Kahn F, Tverring J, Mellhammar L, et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the emergency department[J]. Shock,2019,52(6):e135-e145.
[22]
王彦，吴砚铭，王彦文，等. C反应蛋白/白蛋白比值与肺癌患者预后关系的Meta分析[J]. 华西医学,2019,34(1):50-57.
[23]
Shin WC, Do MU, Woo SH, et al. C-reactive protein for early detection of postoperative systemic infections in intertrochanteric femoral fractures[J]. Injury,2018,49(10):1859-1864.
[24]
Abedini A, Kiani A, Emami H, et al. Serum procalcitonin level as a predictor of bacterial infection in patients with COPD exacerbation[J]. Tanaffos,2019,18(2):112-117.
[25]
张敏，陈浩，曹明. 降钙素原检测在感染性疾病诊断中的价值[J/CD]. 中华实验和临床感染病杂志(电子版),2015,9(5):105-107.
[1] 涂家金, 廖武强, 刘金晶, 涂志鹏, 毛远桂. 严重烧伤患者鲍曼不动杆菌血流感染的危险因素及预后分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 491-497.
[2] 杜滨和, 徐楠, 杨云川, 崔培元. 5项改良衰弱指数预测胰十二指肠切除术近期预后的价值探讨[J]. 中华普通外科学文献(电子版), 2023, 17(06): 444-448.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[5] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[6] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[7] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[8] 宋钰, 赵阳, 王惠君, 廖新华. 术前BMI与可切除胃癌患者术后远期生存的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 530-533.
[9] 汪毅, 许思哲, 任章霞. 胸乳入路腔镜单侧甲状腺叶切除术与开放手术对分化型甲状腺癌患者术后恢复的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 542-545.
[10] 陈俊宇, 崔宇. TAPP治疗腹股沟嵌顿疝的临床分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 546-549.
[11] 赵新亮, 荆克杰, 樊红艳, 王妮, 葸根. 腹腔镜完全腹膜外补片与腹腔内补片治疗两侧下腹壁切口疝的临床对比观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 554-557.
[12] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[13] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[14] 赵立力, 王魁向, 张小冲, 李志远. 血沉与C-反应蛋白比值在假体周围感染中的诊断价值分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 351-355.
[15] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号